Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine for prevention of upper gastrointestinal lesions in low-dose aspirin users
ISRCTN96975557Phase 3Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Apr 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Esophageal ulcer, gastric ulcer and duodenal ulcer comparing Famotidine with Placebo (2 arms). Started Apr 2006; status: completed.
02
Drugs
famotidine
03
Conditions
Esophageal ulcergastric ulcerduodenal ulcer
Beyond the preview
Go deeper on ISRCTN96975557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96975557.